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While various barriers have been identified for the 
implementation of advanced pharmaceutical services, such 
as insufficient information technology (IT) support[1]; some 
have suggested facilitators that could be adopted to 
overcome barriers, for instance the provision of practice-
based training courses including skill-building in 
pharmacotherapy[2].  
Figure 5. Percentage of patients with drug-related problems 
Major discrepancies were found between DRP detected by CP and RT, although only 14 patients of the IG had their 
medication reviewed by CP. The prevalence of PIM found by the RT is consistent with previous studies[7], suggesting 
practicing pharmacists need more support to be able to implement advanced complex interventions in practice. These 
may include continuous professional development courses, online help or software embedded alerts. In future 
medication review implementation studies, the RT should consider more intensive initial courses in order to enable CP 
with the competency to deliver medication review, as suggested by the Portuguese Pharmaceutical Society. 
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Figure 2. Patients with drug-drug interactions 
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Figure 1. Prevalence of Potentially Inappropriate Medicines  
Figure 4. Nature of interactions 
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Figure 3 . Type of interactions 
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To assess the ability of community pharmacists (CP) to 
detect drug-related problems (DRPs), including potentially 
inappropriate medicines (PIMs) and interactions, in elderly 
autonomous outpatients. A secondary objective was to 
compare it with the prevalence detected by an academic 
research team (RT).  
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CP and RT detected respectively 21.2% and 63.0% DRP 
in the IG (Fig. 5).  
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Note: DRP were considered as interactions and/or PIM, as there were insufficient 
data for the RT to judge effectiveness and indication of medicines. 
Inclusion criteria: aged≥ 65  and using ≥ 3 medicines 
A community trial was undertaken in Portuguese 
pharmacies (SOS Pharma Idoso) 
 
Nested study of SOS Pharma Idoso data 
Intervention of CP in level 2 medication review [3], using 
explicit (American Geriatrics Society (AGS) Beers criteria[4]) 
and implicit criteria [5] 
The RT subsequently reviewed the medication in the 
intervention group (IG) and in the entire sample (ES), using 
AGS Beers criteria.  
Interactions were also searched and graded considering 
their level of severity and according to their nature using 
Botplus[6].  
Analysis: Comparison of PIMs detected by CP and RT (Fig.1). 
Description of interactions detected by RT (Fig.2-4). 
Comparison of DRPs detected by CP and RT (Fig.5).  
A sample of 54 patients was analysed, where the                        
mean age was 76.3 years (SD= 7.87), and 70% were     
female. Patients used 8 ± 2.65 medicines. 
